Standard BioTools(LAB)
$0.64-0.02 (-3.31%)
LAB
Standard BioTools financials statements
$0.64
At close:-0.02 (-3.31%)
Want to see LAB full AI Analyst Report?
Standard BioTools (LAB) Income Statement
476 Followers
Standard BioTools Income Statement
Last quarter (Q3 2026), Standard BioTools's total revenue was $19.39M, a decrease of 0.85% from the same quarter last year. In Q3, Standard BioTools's net income was $13.48M. See Standard BioTools’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 85.33M | $ 174.43M | $ 106.34M | $ 97.95M | $ 130.58M | |
| $ 42.54M | $ 84.26M | $ 50.45M | $ 37.05M | $ 69.37M | |
| $ 135.85M | $ 259.50M | $ 127.05M | $ 153.26M | $ 136.83M | |
| Depreciation and Amortization | $ 10.98M | $ 16.86M | $ 15.18M | $ 15.03M | $ 15.57M |
| $ -85.70M | $ -118.14M | $ -54.46M | $ -173.57M | $ -44.27M | |
| $ -93.31M | $ -175.24M | $ -76.60M | $ -116.20M | $ -67.46M | |
| $ -3.40M | $ 36.92M | $ 2.40M | $ -76.72M | $ 3.80M | |
| $ -96.70M | $ -138.31M | $ -74.20M | $ -192.93M | $ -63.66M | |
| $ -74.90M | $ -138.88M | $ -74.66M | $ -190.10M | $ -59.24M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.20 | $ -0.52 | $ -0.94 | $ -2.43 | $ -0.78 |
| Diluted EPS | $ -0.20 | $ -0.52 | $ -0.94 | $ -2.43 | $ -0.78 |
| Weighted Average Shares Outstanding | 381.62M | 352.67M | 79.16M | 78.31M | 75.79M |
| Weighted Average Shares Outstanding (Diluted) | 381.62M | 352.67M | 79.16M | 78.31M | 75.79M |
Currency in USD
